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Abstract: The combination of protein and polysaccharides with magnetic materials has been
implemented in biomedical applications for decades. Proteins such as silk, collagen, and elastin and
polysaccharides such as chitosan, cellulose, and alginate have been heavily used in composite
biomaterials. The wide diversity in the structure of the materials including their primary
monomer/amino acid sequences allow for tunable properties. Various types of these composites are
highly regarded due to their biocompatible, thermal, and mechanical properties while retaining their
biological characteristics. This review provides information on protein and polysaccharide materials
combined with magnetic elements in the biomedical space showcasing the materials used, fabrication
methods, and their subsequent applications in biomedical research.
Keywords: protein; polysaccharide; magnetic nanoparticles; biomaterials fabrication; nanomedicine;
drug delivery; tissue regeneration
1. Introduction
The use of magnetic materials in biomaterials and biomedicine has grown in popularity due to
their broadening applications in the field. Particle size, surface chemistry, and composition are some of
the tunable properties which allow for their integration into clinical drugs and devices [1,2]. Magnetic
nanoparticles (MNPs) are often favored due to their small size and controllable magnetization [3–7].
MNPs are anywhere from a few nanometers to about 100 nanometers in dimension [5,7,8] and often
have different properties compared to those of their bulk counterparts. In addition, magnetic materials
are easily functionalized with other biomaterials such as proteins and polysaccharides that increase
their biocompatibility and usefulness in applications [3,6,7,9]. These combinations of magnetic particles
with proteins and polysaccharides lead to new biomaterials that can be used in various applications.
One such example is tissue engineering where magnetic fields are used to promote the development of
new tissue in response to damage or loss [3,9–11]. Another example is drug delivery where products are
being tested in vivo with magnets to ultimately help release active drug therapies in patients [12–16].
The materials used for the aforementioned magnetic-based applications are diverse but have
similar immunogenic properties that make them ideal for used as biomaterials [17–20]. Protein-based
materials such as silk, keratin, and soy can be degraded in the body without adverse toxicity and have
physical properties that can be tuned to the user’s needs [17,21,22]. These materials are simple to
isolate and utilize enhancing their likelihood of being incorporated into various applications [23,24].
Polysaccharides (e.g., cellulose, chitosan, hyaluronan) are another group of materials that are
inexpensive natural products that provide biocompatibility and diversity in application [18,25].
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Their synthesis, fabrication, and structure allow for their integration with magnetics in order to be
used in biomedical applications.
This review categorizes and describes the characteristics and basic applications of various
protein-based magnetic materials from animals and plants such as silks (Section 2.1.1), keratin
(Section 2.1.2), soy proteins (Section 2.1.3), elastin (Section 2.1.4), and collagen (Section 2.1.5), as well as
polysaccharide-based magnetic materials like cellulose (Section 2.2.1), chitin and chitosan (Section 2.2.2),
hyaluronan (Section 2.2.3), and alginate (Section 2.2.4) (Figure 1). There is a discussion of the types and
properties of various magnetic materials used in magnetic composites as well as a section regarding
recent developments in the techniques for fabrication of such biomaterials. Lastly, we mention various
applications of magnetic biomaterials such as drug delivery systems, cancer cell targeting methods,
and tissue regeneration techniques.
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Figure 1. Magnetic biomaterials can be fabricated from a variety of protein and polysaccharide
sources, including silk, collagen, keratin, and soy proteins, as well as polysaccharides from chitin,
cellulose, hyaluronan and alginate. These natural biopolymers have different molecular structures
and can be processed into magnetic composite materials with tunable properties for various
biomedical applications.
2. Categories of Protein and Polysaccharide Materials
2.1. Protein Materials
Proteins are naturally occurring, linear, unbranched polymer chains, whose primary structure is
composed of anywhere between 50 and 2000 amino acids connected to one another via peptide double
bonds [26]. These series of amino acids and peptide bonds form polypeptide chains, with an α-amino
group or α-carboxyl group. The regularly repeating part of the chain forms the backbone while the
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distinctive side chains vary between proteins [26]. Bonds between α-carbon atoms and the amino or
carbonyl group are singular and allow for freedom of rotation which permits the protein to fold in
many different ways, once again avoiding steric clash [27,28].
There are two major conformations of peptides that are sterically possible and most fully exploit
the hydrogen bonding available within the backbone: the α helix and the β sheet [26,29,30]. The α
helix is a rod-like structure that is formed from a tightly coiled backbone with outward extending side
chains. In β sheets, the polypeptide chain (β strand) is almost fully extended and the side chains of
adjacent amino acids alternate directions [27,28,31]. Linking β strands by hydrogen bonding creates the
β sheet. The linkage can be parallel, where the adjacent chains run in the same direction, or antiparallel,
where they run in the opposite direction [27,28]. Beta sheets can be relatively flat or take on a twisted
shape. The hydrogen bonds between the amine and carbonyl groups of the amino acids stabilize both
the α-helix and the β-sheet conformations [27,28].
The overall folding of proteins is complex and shows little to no signs of symmetry [32]. In most
scenarios, the polypeptide chain folds so that the hydrophobic side chains are buried within the
structure while the polar (hydrophilic) side chains are at the surface. In order for hydrophobic faces of
the secondary structures (α helices and β sheets) to be buried, the amine and carbonyl groups must be
hydrogen bonded. The stability of this overall shape is complemented by Van Der Waals interactions
between tightly packed hydrocarbon side chains [27,28].
Proteins that contain more than one polypeptide chain (subunit) display a fourth level of structural
organization that is based on the spatial arrangement of each subunit and the way in which they
interact with one another. Examples of these include dimers, trimers, and other quantities of identical
subunits within the protein [27,28].
2.1.1. Silk
Silk is a fibrous protein produced by animals from moths and butterflies to spiders and scorpions [33–36].
Its hydrophobic side chains, consisting mainly of glycine, alanine, and serine, allow for the formation of
β sheets within the protein and give silk its notoriously high tensile strength. The hydrophilic amino
acids in the structure of silk provide its elasticity [17,37,38]. Crystallinity of the β sheet can be tuned by
methanol treatments in order to modify its mechanical properties [39,40]. The most extensively studied
and utilized silk comes from the domestic silkworm, Bombyx mori, due to its large-scale production and its
biocompatibility. The cocoon of the Bombyx mori is made from naturally multi-layered silk fibroin fibers that
display a unique hierarchical structure which leads to its specific and singular strength and toughness [17].
Silk from the Nephila clavipes spider has also been popular in recent studies due to its ability to promote cell
adhesion and migration. Both silkworm and spider silks have proven to be promising biopolymers in the
biomaterials industry as tissue scaffolds [17].
2.1.2. Keratin
Keratins are cysteine-rich fibrous structural biopolymers that are the major components of hair,
feathers, nails and horns [41]. Two α helices wind around one another to form its superhelix structure;
one helix is designated type I, the other type II. There are two distinct groups of these proteins based on
the amino acid sequence: hard—short crystalline fibers embedded in a highly cross-linked elastomeric
matrix (hair and nails); and soft—cytoskeletal elements found in epithelial tissues [41,42]. Hard keratins
have large amounts of cysteines that interact through disulfide bonds which give them their enhanced
mechanical strength compared to that of soft keratins. Both groups have intrinsic biocompatibility,
biodegradability, mechanical durability, and natural abundance, making keratins very popular in
studies on their biomaterial applications [22,42,43].
2.1.3. Soy
Soy is a plant-based protein that is obtained from the soybean plant (Glycine max L. Merr.) [44].
This plant is comprised of a heterogeneous assortment of proteins, mainly globular storage proteins
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with two main subunits, conglycinin 7S and glycinin 11S [44]. These subunits both contain non-polar
amino acids: alanine, valine, and leucine; basic amino acids: lysine and arginine; and non-charged
polar amino acids: cysteine and glycine [17]. With the exception of the sulphur-containing amino acids,
soy protein mimics the amino acid patterns of high-quality animal protein sources [44,45]. Soy protein
is highly biodegradable and environmentally friendly, [46] and it is relatively easy to acquire soy due
to its abundance in nature. Soybean products such as soy protein isolate is used as an adhesive in
industrial applications [17]. Its biocompatibility allows for its use in tissue engineered scaffolds and as
a wound dressing [46].
2.1.4. Elastin
Elastin is an extracellular matrix protein that provides elasticity to tissues and organs such as
ligaments, lungs, blood vessels and arteries [47]. It consists of alternating hydrophobic and hydrophilic
domains, wherein the hydrophilic domains there are lysines scattered among alanines. This allows for
the cross-linkage of the molecules, which is further strengthened by the repetition of the hydrophobic
glycines, valines, and prolines [17]. Tropoelastin, the in vivo precursor to elastin, has been targeted for
its use in regenerative medicine. It crosslinks and has a direct impact of the structure and flexibility
on the protein [48]. Elastin protein has a resistance to enzymatic, chemical and physical degradation
which suggests long-term stability in biomedical or biomaterial applications [49,50]. In addition to
stability, its self-assembly behavior, elasticity, and biological activity make elastin-based biomaterials
greatly desirable [49–54].
2.1.5. Collagen and Gelatin
Collagen is the most abundant protein in animals, presenting in the skin and tendons, cartilage,
bone, and most internal organs. It is a fibrous and structural protein that provides structural and
mechanical support [49,51,55,56] and also aids in tissue functions such as scaffolding, morphogenesis,
and repair [57]. There are nearly 30 different types of collagen that have been identified and the three
main types that can be found in the human body are classified as Type I, II, or III. Every type of collagen
contains a repeating amino acid sequence where two amino acids are followed by a glycine. This allows
for a stable three-stranded α helical structure to form. Type I collagen is the most naturally abundant
and is used the most frequently in biomaterial studies [17]. Collagen is a good matrix material for
tissue engineering due to its ability to act as a natural substrate for cell attachment and allows for the
development of bioengineered tissue scaffolds [17,58]. Gelatin is derived from collagen hydrolysis and
is a biodegradable, bioresorbable material [59–61]. It is found as a mixture of peptides and type A
(acid hydrolysis) and type B (alkaline hydrolysis) are the two gelatins that are usually formulated from
native collagen [60]. These biomaterials are favorable due to their low cost and biocompatibility [59,62].
Recently the chemical and physical structure of gelatin has led to its use as a drug carrier agent and in
cell imaging applications [62].
2.2. Polysaccharide Materials
Polysaccharides are relatively complex carbohydrates that are formed from ten or more repeating
monosaccharides or disaccharides [63,64]. They are generally more stable than proteins since they are
usually not irreversibly denatured when heated [65]. Additionally, polysaccharides possess linear or
branched structure and can be monofunctional or polyfunctional. Other beneficial properties include
their high levels of chirality, water solubility or insolubility, and low toxicity [18,64]. There are storage
(starch and glycogen) and structural (cellulose and chitin) polysaccharides. Most polysaccharide-based
biomaterials are derived from structural polysaccharides, and their use in the biomedicine field
is expanding.
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2.2.1. Cellulose
Cellulose is a structural polysaccharide that is contained within the cell walls of plants and
animals [66,67]. Long polymer chains of glucose units connected by β-acetal linkages form its
crystalline structure, where β-glucose molecules join together to create a polymer [67]. Due to the
intramolecular hydrogen bonding within the joined glucose, cellulose can form very rigid fibers [68].
Different types of cellulose can be formed through unique methods, such as treating natural cellulose
(cellulose I) with sodium hydroxide, soaking it in cold (approximately −80 ◦C) liquid anhydrous
ammonia, or soaking it in hot (approximately 200 ◦C) glycerol. These methods transform cellulose I into
a crystalline matrix with a different set of properties. Of these, cellulose II (made by treating cellulose I
with sodium hydroxide) is the most thermodynamically stable [18]. The aforementioned properties
such as stability in temperature and mechanical properties allow for the fabrication of cellulose.
2.2.2. Chitin and Chitosan
Chitin is a long, linear chain of N-acetyl-d-glucosamine residues that naturally forms highly
crystalline ordered networks. The arrangement of chains in chitin can be designated as α, β, and γ
chitin. α-chitin is mostly found in arthropods and crustaceans, and has chains in a parallel arrangement;
β-chitin has an antiparallel arrangement; and γ-chitin is a combination of parallel and antiparallel
where out of every three chitin chains, two are parallel and one is antiparallel [18,69]. Chitin is
widely distributed among plants and animals and even found in the cell wall of fungi and algae.
Its strong intermolecular interactions through hydrogen bonding improve the rigidity of chitin and
limit its solubility.
Chitosan is also a linear polysaccharide composed of β-(1,4)-linked D-glucosamine and is
obtained by extensive deacetylation of chitin. Unlike chitin, chitosan is soluble in dilute aqueous
solutions. It has many properties that make it favorable to the biomedical community, such as its
bioactivity, antimicrobial activity, immunostimulation, chemotactic action, enzymatic biodegradability,
mucoadhesion and epithelial permeability [70,71].
2.2.3. Hyaluronan
Hyaluronan (hyaluronic acid) is a simple, water-soluble polysaccharide [72] whose structure is
an unbranched glycosaminoglycan chain that is formed from repeating disaccharide units containing
D-glucuronic acid and N-acetyl-d-glucosamine. It is expressed in the extracellular matrix, on the cell
surface, and inside the cell where it functions to maintain tissue hydration and lubrication [73]. It is
also found in soft connective tissues, joints, skin, eyes, and other tissue-derived organs. Hyaluronan is
important in homeostasis of plasma proteins and is thought to have a role in the mitotic process due to
its ability to help cells proliferate [74].
Hyaluronan has unique hydrophilic, rheological, and viscoelastic properties that contribute to its
significant role in biological processes and make it a good biomaterial [75]. The matrix of this polysaccharide
allows for cells to be in a hydrated environment and can increase their development [75,76]. Applications in
biomedicine to date include use as a serum for eye surgery and various other inflammatory conditions [74].
2.2.4. Alginate
Alginates are carboxylic polysaccharides that are produced almost exclusively in brown algae.
Their major components are the L-guluronate and D-mannuronate residues, whose ratio varies
depending on the natural source and form linear copolymers [77–79]. It is believed that only the
α-L-guluronate residues participate in intermolecular cross-linkage in order to form hydrogels; therefore,
the guluronate/mannuronate ratio, overall sequence, and length of the guluronate blocks are the driving
factors affecting the physical properties of alginate and its hydrogels [77–79]. They have a thickening
characteristic that allows them to increase the solvent viscosity upon dissolution, thus allowing for
physical stabilization within the solution. Their ionic change aptitude and gel-forming ability in the
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presence of multivalent counterions is a direct consequence of alginates being polyelectrolytes and is
why they follow the usual behavior of charged polymers. When in a fibrous or film form, alginate is
used as hemostatic materials and wound dressings [72].
3. Magnetic Properties of Materials for Biomedical Applications
3.1. Magnetism of Materials for Composites
Table 1 lists typical magnetic particles used today in various medical applications. The defining
characteristic of a magnetic material is the magnetization M, the net magnetic moment per unit
volume and is dependent on the magnetic field H. The particular response depends upon the type
of magnetic material for which there is great diversity, including diamagnetic, antiferromagnetic,
ferromagnetic, ferrimagnetic, paramagnetic, and superparamagnetic phases. Since most of the
nanocomposites rely upon maximizing the magnetic forces, this discussion will focus on ferromagnetic
and superparamagnetic materials.
Table 1. Common medical applications of magnetic particles used today.
Structure Composite Materials Example Biomedical Applications
Magnetite
(Fe3O4)
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Many of the magnetic materials used in composites are nanoparticles of ferromagnetic materials;
however, their small size alters their magnetic properties from that of a bulk material as first discussed
by Néel [93]. The strong exchange interaction ensures that all spins are aligned with each other
but the magnetic anisotropy which gives rise to a preferred magnetic orientation is much weaker
and scales with the volume. When the particles are small enough, the thermal energy can be larger
than the anisotropy energy, and so the magnetization direction can wander. Such a system is called
superparamagnetic in that it acts like a paramagnet with noninteracting moments that align with H
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except that instead of the moment being that of a particular ion, it is the moment of an entire particle.
Such superparamagnetic systems are generally anhysteretic and have a large susceptibility:
χ = dM/dH (1)
3.2. Shape Effects of Magnetic Particles
For any finite size object, there are dipolar fields which emanate from the object due to the
magnetization. Since the magnetic field lines always form closed loops, this demagnetization field Hd
opposes the magnetization (Figure 2C). The actual magnetic field
H = Happ + Hd (2)
where
Hd = −NM (3)
and Happ is the applied magnetic field and N the demagnetization factor. For spherical particles,
N = 1/3. For long rods, N = 0 along the axis and N = 1/2 in the transverse direction. For the special
case of ellipsoids, the magnetization is uniform inside, and the values for N have been worked out
by Osborn [94].
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3.3. Forces and Torques on a Magnetic Sample
The magnetic energy density u is given by
u = −µ0M·H (4)
where µ0 is the permeability of vacuum. Since most particles are often approximately spherical or
spheroidal in shape, M is uniform throughout the particle if H is uniform, which is a reasonable
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approximation given that the gradient in H will have a much larger length scale than the submicron
scale of the particle. However, if the particle density is sufficiently large, this assumption may break
down due to dipolar fields from neighboring particles. Note that it is these dipolar fields which
generally contribute to the contrast enhancement in MRI by magnetic nanoparticles.
The force F on a given magnetic particle is given by negative the gradient of the potential energy
U, and if we assume that the density is small enough to ignore particle-particle interactions, then
F = −∇U = −µ0V∇(M·H) ≈ µ0V(M·∇)H (5)
where V is the volume of the particle. The rightmost equation is true because ∇ ×H = 0 since there are
no currents in the sample and because M is nearly uniform. In essence, the force is dependent on the
product of the M and the gradient in H although one needs to keep in mind that M itself is dependent
on H.
The magnetic torque density τ is given by
τ = µ0M × H (6)
If Happ is not along a principle axis of the object, then H and M are not parallel. Thus, magnetic
particles, even in a uniform field, can experience magnetic torques (Figure 2D). The magnetic torque has
a tendency to align the axis of the object with the smallest value of N to the magnetic field. This means




Table 2 summarizes advantages, parameters and applications of common magnetic material
fabrication methods based on proteins or polysaccharides. Electrospinning is a unique technique for
fabricating protein or polysaccharide-based magnetic materials. The process of electrospinning was
developed over one hundred years ago [95,96] and uses electrostatic forces to fabricate thin, nanoscale
fibers. A syringe pump, DC power supply, and ground collector are the primary components of
an electrospinning system (Figure 3) [96–101]. An electric potential of about 15~20 kV is needed to
maintain the process and is used in the two main conventional setups, vertical and horizontal [102].
The methods allow for different ways to collect the fibers, and the process itself is constantly being
updated to form fibers with varied orientations [103,104]. When the potential is applied, charge
induction will form what is known as a Taylor cone due to surface tension and electrical force [96,97].
When the electrical force exceeds the capillary pressure, fibers are drawn from a droplet that forms at
the top of a spinneret [96] and guided to the ground collector [105–107].
There are a number of factors that affect the fiber properties including the applied voltage,
temperature, and humidity, among others. Normally, electrospinning is done at room temperature,
and the resultant fibers often range in size from nanometers to microns [108–111]. Many types of fibers
can be produced such as polymer, composite, and synthetic which have led to electrospinning’s use in
a variety of fields [96,100,112,113].
Electrospun fibers with magnetic particles can be used in a variety of biomedical applications
that include tissue engineering [114,115] and drug delivery [116,117]. The success of the former
is because the nanofibers have high surface areas and therefore promote adhesion, proliferation,
and differentiation of cells [118,119]. Magnetic composite fibers have been synthesized by adding the
magnetic nanoparticles to the solution prior to processing the fibers [84]. Cobalt ferrite (CoFe2O4)
and magnetite (Fe3O4) are commonly used magnetic nanoparticles, and their presence can alter the
physical properties of the fibers. [7,84,120,121].
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Film casting is often used to prepare nanocomposites [18]. with magnetic and polysaccharide-
based materials having been used. Cellulose and chitosan are examples of polysaccharides that are 
used in film casting that have strong thermal stability [127,128]. Copper and gold particles that were 
degassed have been used to produce films that possess magnetic properties [129]. Film casting has 
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Figure 3. (A) Com on vertical set-up for electrospinning, along with (B) an example of chitosan nanofibers
with MNPs (Scale in B: 100 nm). (B is reproduced from open access Ref [122], De Gruyter, 2017).
4.2. Film Casting
Thin sheets or films can be produced via the film-casting method which is shown schematically in
Figure 4 [123–125]. This fabrication method is similar to electrospinning but differs in the direction
that the film/sheet is drawn; this process stretches the film/sheet planarly. The molten solution in
a solvent is added to a flat-surfaced moving belt. The solution will spread out, cool, and dry on the
belt, completely removing the solvent, and the dry film can then be removed [125]. This method
can produce films or sheets anywhere from about ten to a few thousand microns in thickness and
with large widths of up to a few hundred centimeters [124,126]. The speed of the film casting process
determines the ratio of the film thickness to its width and influences the physical properties [124].
Film casting is often used to prepare nanocomposites [18]. with magnetic and polysaccharide-based
materials having been used. Cellulose and chitosan are examples of polysaccharides that are used
in film casting that have strong thermal stability [127,128]. Copper and gold particles that were
degassed have been used to produce films that possess magnetic properties [129]. Film casting has
been used to modulate the antimicrobial properties, transparency, and thermally conductivity [18] of
composite biomaterials.
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Figure 4. (A) Example of the set-up for the film casting process. Seen below (B,C) are two examples
of films casted that are made from chitosan. (B) is an SEM micrograph (Scale 100 µm) and (C) is
a topographic image of the surface of the film. ((B,C) are reproduced with permission from Ref [127],
Copyright RSC Publishing, 2009).
4.3. Dip Coating
The dip-coating process has been commercially in use since 1939 [130]. It is a relatively simple
process that has been sinc used for thin fil s and sol-gel t ch ology. Dip coating involves immersion
of a substrate in th desired solution to create a layer f the soluti n on the substrate [131–133].
This meth d utilizes chemical interactions such as hydrophobic effects and electrostatic nd ionic
interactions. In general, the process is split nto five steps: immersion, startup (substrate remains in
solution), deposition, drainage, and evaporation [133]. This rocess can be beneficial for objects th t are
irreg lar or complex i shape [125,132]. Though it was primarily d ne by hand at first, the aut mation
of dip coating has been us d commercially to enhance reproducibility. The be fits of dip coating also
include a easily adjustable thickness layer, convenience, and low cost; however one downside i the
possible blocking of the “screen” of the substrate which can change the pro uct’s function [130,131].
Th re are multiple factors that influence dip c ating results such as the rate of cond nsation and
evap ration, capillary pressure, and withdrawal speed [134,135]. The film thickness specifically is
determined by capil ary f ce and gravity [134,135]. Other factors in process are vi cous drag,
surface te sion [131,132] and density [136].
Dip coating can be used to synthes ze magnetic nanocomposites with a protein or polysaccharide
matrix (Figure 5) [18]. A dip-coa ed composite of silver and chitosan has demonstrated enhanced
thermal properties for antimicrobial applications [137]. Dip-coating techniques have also been
con idered allow fo use in therapeutic biome ical applications such as ti sue engineering [18,138].
Int. J. Mol. Sci. 2020, 21, 186 11 of 25
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 11 of 25 
 
 
Figure 5. Schematic of the dip coating process showing the dipping, deposition of MNPs and 
evaporation to create the protein or polysaccharide magnetic material that can be used in biomedical 
applications. 
4.4. Infusion Gyration 
Infusion gyration is another process that has been developed to fabricate fibers [14,139–141]. 
Seen in Figure 6, the device has a hollow aluminum vessel with small holes. The system is powered 
by a DC motor and its rotational speed is controlled [14,139]. A syringe pump controls the flow into 
the spinning vessel, and fibers are collected on aluminum foil sheets in the container [14,139]. 
Differences in fiber size and size distribution can be attributed to the shape and volume of the 
polymer droplets flow at different rates at the opening of the apparatus [139]. The fibers that are 
created are also impacted by the concentration and viscosity of the solution that is infused into the 
vessel [102,140]. 
This method comes from a pressurized gyration technique [140] that helped Zhang et al. develop 
the Berry number (Be) to represent fiber size. In their experiment a Be score of less than 1.6 would 
not result in nanofibers because of low polymer chain entanglement while a score of above 4.8 
resulted in a thick fiber. They came to the conclusion that speed for infusion gyration should be 
around 36,000 rpm for fiber formation [139]. 
The flow rate can be adjusted to tune the properties of the fibers to engineer smooth and well-
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to create the protein or polysaccharide magnetic material that can be used in biomedical applications.
4.4. Infusion Gyration
Infusion gyration is another process that has been developed to fabricate fibers [14,139–141].
Seen in Figure 6, the device has a hollow aluminum vessel with small holes. The system is powered by
a DC motor and its rotational speed is controlled [14,139]. A syringe pump controls the flow into the
spinning vessel, and fibers are collected on aluminum foil sheets in the container [14,139]. Differences
in fiber size and size distribution can be attributed to the shape and volume of the polymer droplets
flow at different rates at the opening of the apparatus [139]. The fibers that are created are also impacted
by the concentration and viscosity of the solution that is infused into the vessel [102,140].
This method comes from a pressurized gyration technique [140] that helped Zhang et al. develop
the Berry number (Be) to represent fiber size. In their experiment a Be score of less than 1.6 would not
result in nanofibers because of low polymer chain entanglement while a score of above 4.8 resulted in
a thick fiber. They came to the conclusion that speed for infusion gyration should be around 36,000 rpm
for fiber formation [139].
The flow rate can be adjusted to tune the properties of the fibers to engineer smooth and
well-aligned fibers. This method has been used to fabricate protein nanofibers which have potential
biomedical applications due to their biocompatibility. Subsequently, magnetic composite nanofibers
have been synthesized and for candidates as drug-release agents and as materials for imaging [14,139].
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Table 2. Advantages, parameters, and applications of the common protein or polysaccharide based
magnetic material fabrication methods. Source [14,18,84,108–111,118,119,124–128,132,134–137,139].
Composite Composition Advantages Parameters Affecting Process Applications
Electro-
spinning
• Chitosan and iron (II) and iron
(III) salts [122]
• Chitin and iron chloride [143]
• Cellulose acetate and silver
nanoparticles [144]




• Large surface area
per mass
• Small pore size












• Cellulose and chitosan with
gold nanoparticles [127,128]
• Iron oxide and chitosan [145]





• Strong thermal stability
• Speed of process







• Silver and chitosan [137]














• Viscosity and density of
coating material


















• Speed of rotation
• Magnetic actuation
• Drug release
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Figure 6. Infusion gyration method of fabrication and examples of fibers created from this method.
For example, these fibers are fabricated with the addition of Fe particles at a speed of 36,000 rpm [14,142]
(Scale bar is 25 µm). (Reproduced with permission from Refs [14,142], ref. [142]: Copyright John Wiley
and Sons, 2017; ref. [14]: American Chemical Society, 2018, further permissions related t the material
excerpt d should be irected to the ACS).
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5. Recent Magnetic Applications of Protein and Polysaccharide Materials
5.1. Tissue Regeneration
The applications of tissue engineering are expanding rapidly with great promise to create diverse
new tissues to treat various human conditions [3,9–11,148,149]. Magnetic nanoparticles and magnetic
cationic liposomes are currently being implemented in force-based tissue engineering [3,150,151]
while some tissue engineered constructs have been coated with a mixture of iron oxide particles and
collagen [10]. These studies demonstrate that magnetic scaffolds can help improve adhesion and
proliferation of various progenys of cells including bone marrow, bone, adipose, cartilage, and tendon
while remaining biocompatible [10,24,152].
The combination of chitosan and magnetic material was investigated by Sasaki et al. [153] to
show its abilities in the tissue engineering and regenerative medicine space (Figure 7A). The magnetic
nanoparticles were coated with chitosan and then added into cells. Cylindrical neodymium magnets
were used in this study. This enhanced the cell seeding in 3D scaffolds—A crucial issue in tissue
engineering. Cells often do not penetrate the tissue engineering construct and will remain superficial.
The magnetic force was able to push the seed cells deeper into the scaffolds. The degree of magnetic
force directly impacted how effective the invasion was. Cell-to-cell interactions and proliferation times
were improved with MNPs. The chitosan aided in the biocompatibility and biodegradability of the
MNPs as well. Cells were approximately 80% viable after the addition compared to 100% of the control.
This study showed promise and the hope for future designs that will lead to more cell infiltration in
tissue engineering.
Bock et al. [10] presented another application of magnetic scaffolds that used hydroxyapatite and
collagen (Figure 7B). There scaffolds were fabricated by dip-coating methods that added ferrofluids
with iron oxide particles. They concluded that their scaffolds should be further looked at for tissue
engineering applications. The proliferation of human bone marrow stem cells in vitro was achieved.
The magnetic nanoparticles were also able to be guided in the scaffold. This did not affect the scaffold,
which is essential to keep the porosity and shape of the construct [10].
Another study of collagen and MNPs was done by Panseri et al. [91] (Figure 7C). These scaffolds
were in vivo and had external magnets that helped to control regeneration. The orientation of the
scaffold was affected by the magnetics and the ECM was deposited similar to the orientation [89,91,154].
A NdFeB magnet was used and created a static magnetic field that augmented the bone tissue
engineering. The magnets were able to “fix” the scaffold and reduce the need for pin fixation that
is commonly used in bones. The overall goal in this study is to help with engineering of osseous
structures like metaphyseal bone [89].
Tissue engineering will be a large focus of protein and polysaccharide magnetic materials for
years to come. There are many applications that are still being investigated to promote proliferation
and adhesion of cells in vivo. The magnetic composites have shown to respond to magnetic fields
along with the ability to move cells and elements (e.g., growth factors) of the scaffold while the protein
and polysaccharide materials allow for better biocompatibility. This combination of tissue constructs
could ultimately lead to greater control over cell behavior and expansion.
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Studies have shown that protein and polysaccharide composite magnetic materials are 
advantageous for drug delivery due to their timed release [12–16,155–158]. There are efforts to use 
these materials to produce targeting systems where the magnetic portion of the biomaterial can be 
guided to a specific site in vivo [12,15,159–161]. Drug-laden silk fibroin magnetic nanoparticles have 
been used in cancer research to access tumor sites [138,162]. Various polysaccharides such as heparin 
and chitosan have been used with superparamagnetic iron oxides in the delivery of anticancer drugs 
and for tumor tagging capabilities [18,80,83]. 
Tian et al. [162] presented a novel cancer drug therapy with silk fibroin and magnetic 
nanoparticles (Figure 8A). Their process was to salt out silk fibroin with doxorubicin (DOX) and 
magnetite MNPs. The combined particles were tested on a human breast adenocarcinoma cell line 
(MCF-7 cells) and its resistant counterpart (MCF-7/ADR cells). An external magnetic field was 
applied to guide the drug to these resistant tumors in mice. According to their results, the tumors 
Figure 7. Examples of tissue engineered scaffolds with protein or polysaccharide magnetic combinations.
(A) Hydroxyapatite-collagen scaffold with magnetic nanoparticles dip coated on them (image width:
2500 µm). (B) Magnetic nanoparticles with chitosan. The white arrows show the MNPs and this image
shows cells seeded on the scaffold (image width: 3.84 µm). (C) A NdFeB magnet placed in bone
showing influence of magnet on cells (image width: 6.39 mm). (Reproduced with permission from
Refs [10,91,153], (A) Copyright Elsevier, 2010; (B) Elsevier, 2007; (C) John Wiley and Sons, 2013).
5.2. Drug Delivery
Studies have shown that protein and polysaccharide composite magnetic materials are advantageous
for drug delivery due to their timed release [12–16,155–158]. There are efforts to use these materials to
produce targeting systems where the magnetic portion of the biomaterial can be guided to a specific
site in vivo [12,15,159–161]. Drug-laden silk fibroin magnetic nanoparticles have been used in cancer
research to access tumor sites [138,162]. Various polysaccharides such as heparin and chitosan have
been used with superparamagnetic iron oxides in the delivery of anticancer drugs and for tumor
tagging capabilities [18,80,83].
Tian et al. [162] presented a novel cancer drug therapy with silk fibroin and magnetic nanoparticles
(Figure 8A). Their process was to salt out silk fibroin with doxorubicin (DOX) and magnetite MNPs.
The combined particles were tested on a human breast adenocarcinoma cell line (MCF-7 cells) and its
resistant counterpart (MCF-7/ADR cells). An external magnetic field was applied to guide the drug to
these resistant tumors in mice. According to their results, the tumors grew more extensively when
magnets were not attached to the drug-loaded silk fibroin while the silk fibroin helped to protect the
mice from the toxic effects of the chemotherapeutic drug. This study demonstrated in vivo tumor
targeting and drug delivery that could be effective against multidrug resistant forms of cancer using
the synergistic properties of MNPs and silk fibroin composite.
Another study on drug delivery was done by Javid et al. [80] using heparin-coated superparamagnetic
iron oxide nanocomposites (Figure 8B). They used DOX and paclitaxel (PTX) within the core of the
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nanocomposites with A2780 and OVCAR-3 human ovarian cancer cells. The results showed DOX and
PTX being released steadily with the application of a magnetic field, and the heparin allowed for higher
uptake of the drugs along with great suppression of tumor growth. Doses of 10 µg mL−1 caused apoptosis
in the tested cells at rates above 75%. The authors concluded that the tumor cells were internalizing the
heparin-coated loaded nanocomposites.
Song et al. [163] used silk fibroin in conjunction with MNPs to deliver curcumin (Figure 8C),
an anticancer drug has limitations such as low bioavailability, poor solubility, and short half-life.
The goal of this study was to improve the effects of the drug with the introduction of the magnetic
silk fibroin core. A breast adenocarcinoma cell line (MDA-MB-231cells) was tested. The nanoparticles
could be modified by changing the silk and curcumin concentrations which affected the zeta potential,
loading efficiency, and release rate. It was found that the drug could be made to be released over
a period of up to 20 days, and the nanoparticles were able to inhibit growth of the cancer cells.
In another drug delivery system, gelatin was used with Fe3O4 nanoparticles [164]. The particles
were shown to be distributed throughout the matrix and the applied magnetic fields increased the
release rate of vitamin B-12 [164]. Gelatin and magnetic silica mesoporous nanoparticles were used to
deliver paclitaxel [165]. These results showed some preliminary anti-tumor efficacy with the use of
an external magnet [165].
Drug delivery methods that have been fabricated with magnetic materials and both proteins
and polysaccharides have been growing in magnitude considerably in the past decade. Magnetic
composite materials have been shown to be able to reduce toxicity of the drug and be able to target
specific ligands. The addition of biomaterials and magnetics help to bring forth future applications that
allow for more efficacious drug delivery and hopeful stronger therapeutics in common, debilitating
diseases such as cancer.
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5.3. Nanomedicine and Other Biomedical Applications
Magnetic resonance imaging (MRI) was one of the first implementations of magnetism into the biomedical
field and has since been expanded to include various aspects of medicine and nanomedicine [83,166].
Alginate has been introduced for use in MRI to aid in cell tracking and to act as a negative control contrast
agent [81–83,167]. Cellular therapies and labeling are now being implemented with MNPs in conjunction
with polysaccharides and proteins to improve medicine [168–175].
Shen et al. [81,82] have described a way to use alginate microcapsules for MRI (Figure 9B).
The microcapsules contain ferrofluid made from iron oxide and alginate and can be accessed without
surgery. The ferrofluid microcapsules can be seen with MRI because of a reduction in the T2 relaxation
time which increases the contrast, making it visible compared to the alginate alone. This can be used
for in vivo tracking of microcapsules to see the effects in the body in real time.
Magnetic nanoparticles have also been used in protein purification. The addition of MNPs into
the process allowed for high-resolution separations without the need for centrifugation, membrane
separation, or filtration. An example of this was shown by Chiang et al. [176] who used phosphopeptides
MNPs, and the tagged fusion proteins could be extracted from E. coli with high yields [151,176].
Targeting is the effort to locate evasive cancer cells which can then be tagged in vivo. This has
been another active area of investigation for magnetic nanoparticles and proteins/polysaccharides.
In a study done by Pulfer and Gallo [168] with magnetic aminodextran microspheres, they were
able to locate glioma tumors in rats (Figure 9C). The particles were able to remain in the brain for
extended time periods and the administration of the magnetic field could change the tissue distribution.
Daldrup-Link et al. [169,170] were able to label human hematopoietic progenitor cells with magnetic
polysaccharide nanoparticles that could change the relaxation rate and thus change the MRI imaging.
Signal intensities were improved with the addition of these contrast agents, providing another way to
locate cells in the body and tag them.
Cancer cell death and the shrinking of solid tumors have been enhanced with the use of magnetic
hyperthermia in recent studies [177–180]. The temperature is raised to 40–43 ◦C and the effects of
chemotherapy are inceased with the induction of heat [179]. Cell viability and protein denaturation are
affected by even a raise in a half of degree [179]. Chang et al. [178] used uniform magnetic nanoparticles
of iron oxide and coated it with human-like collagen protein. An alternating magnetic field was able
to raise the temperature faster than non-collagen-coated nanoparticles. This application was able to
increase biocompatibility with a protein coating that could lead to further use of these composites for
magnetic hyperthermia in the future.
Nanoparticles will continue to be used in various biomedical applications. Though tissue
engineering and drug delivery are the most commonly used, targeting and MRI are some other
examples of the diverse power of MNPs with proteins and polysaccharides. It is expected that these
materials can be used in microgel assembly and mimic cell functions as the technology continues
to develop [3,181].
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